Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review

Blau syndrome (BS) is an autoinflammatory disorder characterized by non-caseating granulomatous dermatitis, arthritis, and uveitis. We present a case of refractory and severe BS that was treated with the Janus kinase inhibitors (JAKINIBS), Tofacitinib (TOFA) and then Baricitinib (BARI). Our aim was...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-Reguera, Carmen, Prieto-Peña, Diana, Herrero-Morant, Alba, Sánchez-Bilbao, Lara, Martín-Varillas, José Luis, González-López, Elena, Gutiérrez-Larrañaga, María, San Segundo, David, Demetrio-Pablo, Rosalía, Ocejo-Vinyals, Gonzalo, González-Gay, Miguel A., Blanco, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058350/
https://www.ncbi.nlm.nih.gov/pubmed/35510170
http://dx.doi.org/10.1177/1759720X221093211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058350/
https://www.ncbi.nlm.nih.gov/pubmed/35510170
http://dx.doi.org/10.1177/1759720X221093211

Ejemplares similares